ArticleTrials2025

The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy.

Gioia Riboni-Verri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.